William West

CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom.

Cancer Targeting Systems, Inc. offers cancer care. The firm focuses on delivering cancer theranostic products combining imaging with therapy. The company was founded by Martin Pomper and Will West and is headquartered in Boston, MA.

John Innes Centre Ltd. provides research services in plant science and microbiology. It carries out fundamental research to train scientists and make their findings available to society. The scientific research at the center makes use of a range of disciplines in the biological and chemical sciences, including cell biology, biochemistry, genetics, molecular biology, computational and mathematical biology. The company was founded in 1910 and is headquartered in Norwich, the United Kingdom.

Cyted Ltd. provides digital diagnostic infrastructure to know the early detection of cancer. The company was founded by Marcel Gehrung, Rebecca Fitzgerald, and Maria O'Donovan and is headquartered in Cambridge, the United Kingdom.

PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom.

VaxEquity Ltd. is a UK biotechnology company founded in 2020 by Professor Robin Shattock, the head of immunology of infection at Imperial College and Morningside. The company is based in Little Chesterford, UK. The British company is developing transformative RNA therapeutics and vaccines using its next-generation self-amplifying RNA platform called SARNA. The platform provides extended duration of protein expression, enabling lower doses to be used for vaccines and higher protein levels to be achieved for therapeutics. VaxEquity is pioneering a next-generation approach by modifying its SARNA to modulate the innate immune response and thereby overcoming current limitations. The flexibility of the company's platform ensures that its broad pipeline of assets can be designed, developed, and manufactured rapidly and at scale.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Procter & Gamble Ltd. manufactures and markets consumer products. It provides fabric and home care products which include laundry, cleaning, detergents, soaps, softeners, and cleansers. The company was founded in 1837 and is located in Newcastle, UK.

CellFactors Plc develops therapeutic products derived from human cells. The private company is based in Babraham, UK.